| BURNING ROCK BIOTECH LTD ADR |
| USA |
| Gesundheit |
| US12233L2060 / A40AE6 |
| 6BU0 (Frankfurt) / BNR (NASDAQ) |
| FRA:6BU0, ETR:6BU0, 6BU0:GR, NASDAQ:BNR |
| - |
| https://www.brbiotech.com.. |
|
Burning Rock Biotech Limited American Depositary Receipt represents a precision oncology company specializing in next-generation sequencing (NGS)-based diagnostics for cancer therapy selection. The company provides advanced cancer genotyping technolo..
>Volltext.. |
| 152.03 Mio. EUR |
| 97.74 Mio. EUR |
| 65 Mio. EUR |
| -5.33 Mio. EUR |
| -6.68 Mio. EUR |
| -0.62 EUR |
| 5.35 Mio. EUR |
| 59.64 Mio. EUR |
| -3.42 Mio. EUR |
| 1.95 |
| 4.69% |
| 83.98% |
| - |
| - |
| - |
| - |
| BURNING ROCK |
| 05.04.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|